Safety, Feasibility, and Cost-Effectiveness with Outpatient Administration of High-Dose Cytarabine Consolidation in Acute Myeloid Leukemia

被引：0
|
作者：
Wetzstein, Gene A. [1 ]
Lancet, Jeffrey E. [1 ]
Kallner, Jennifer E. [2 ]
Sivik, Jeffrey M. [3 ]
Ho, Viet Q. [1 ]
George, Timothy J. [1 ]
Desai, Sheetal [1 ]
Fisher, Shanel [1 ]
Newton, Michael D. [4 ]
List, Alan F. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Indiana Oncol Hematol Consultants, Indianapolis, IN USA
[3] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[4] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：838 / 839
页数：2
相关论文
共 50 条
  • [1] Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia
    Li, Wenhui
    Richter, Katherine
    Lee, Jamie
    McCarthy, Kevin
    Kubal, Timothy
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1812 - 1818
  • [2] Safety and feasibility of outpatient high-dose cytarabine (HIDAC) and intermediate-dose cytarabine (IDAC) for consolidation therapy in acute myeloid leukemia (AML).
    Li, Wenhui
    Simondsen, Katherine
    Lee, Jamie
    Elharake, Maher
    Kubal, Timothy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Safety and Feasibility of Outpatient High-Dose Cytarabine Consolidation in AML Patients
    Waller, Allyson
    Brown, Shelly
    Freeman, Tracelyn
    Kumar, Pooja S.
    Mims, Alice S.
    BLOOD, 2022, 140 : 5086 - 5087
  • [4] Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia
    Ng, Chin-Hin
    Chen, Xiaojuan
    Lee, Foong-Gwan
    Choong, Shi Hui Clarice
    Saw, Xiao-Shi
    Sai, Lon-Wann
    Poon, Michelle
    Chan, Hian Li Esther Hian Li
    Ooi, Melissa
    Chee, Yen Lin
    Lee, Yee Mei
    BLOOD, 2019, 134
  • [5] Outpatient Cytarabine Administration Is Safe and Effective For Consolidation In Acute Myeloid Leukemia
    Allen, Marci R.
    Aljitawi, Omar S.
    He, Jianghua
    Abhyankar, Sunil
    Ganguly, Siddhartha
    McGuirk, Joseph P.
    Lin, Tara L.
    BLOOD, 2013, 122 (21)
  • [6] Safety and Cost-effectiveness of Outpatient Administration of High-dose Chemotherapy in Children With Ewing Sarcoma
    Elshahoubi, Alya
    Alnassan, Anwar
    Sultan, Iyad
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (03) : E152 - E154
  • [7] Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine
    Lopes, Lais Moreira
    Nucci, Marcio
    Portugal, Rodrigo Doyle
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 397 - 401
  • [8] Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia
    Schlenk, Richard F.
    HAEMATOLOGICA, 2024, 109 (06) : 1629 - 1630
  • [9] Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation
    Mcclellan, Kristen
    Messina, Julia
    Saullo, Jennifer
    Huggins, Jonathan
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5351 - 5358
  • [10] Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).
    Nunnery, Sara
    Wang, Dorothy
    Tan, Marisela
    Fong, Richard
    Lo, Mimi Ming
    Olin, Rebecca L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345